Multiscale pharmacokinetic modeling of systemic exposure of subcutaneously injected biotherapeutics
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiscale pharmacokinetic modeling of systemic exposure of subcutaneously injected biotherapeutics
Authors
Keywords
mAb, Simulation, Subcutaneous absorption, Biotherapeutics, Physiologically-based pharmacokinetics, Multiscale modeling, Bioavailability
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 337, Issue -, Pages 407-416
Publisher
Elsevier BV
Online
2021-07-27
DOI
10.1016/j.jconrel.2021.07.043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Model Development
- (2021) Fudan Zheng et al. PHARMACEUTICAL RESEARCH
- Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Sensitivity Analysis
- (2021) Peng Hou et al. PHARMACEUTICAL RESEARCH
- Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics
- (2020) DavidS. Collins et al. JOURNAL OF CONTROLLED RELEASE
- Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
- (2020) Manuel Sánchez-Félix et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects
- (2020) Zhaoyang Li et al. Clinical Pharmacology in Drug Development
- Subcutaneous delivery of biotherapeutics: challenges at the injection site
- (2019) Joana A. D. Sequeira et al. Expert Opinion on Drug Delivery
- Five computational developability guidelines for therapeutic antibody profiling
- (2019) Matthew I. J. Raybould et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms Influencing The Disposition Of Monoclonal Antibodies And Peptides
- (2019) Amita Datta-Mannan DRUG METABOLISM AND DISPOSITION
- Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis
- (2019) Amit Khatri et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial
- (2019) Shaila Shabbir et al. Clinical Pharmacology in Drug Development
- Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologics
- (2019) Kenneth C Anderson et al. Future Oncology
- Removal of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in rats
- (2019) Ian K. Styles et al. JOURNAL OF CONTROLLED RELEASE
- Pharmacokinetics of Tildrakizumab (MK-3222), an Anti-IL-23 Monoclonal Antibody, After Intravenous or Subcutaneous Administration in Healthy Subjects
- (2018) Sauzanne Khalilieh et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins
- (2018) Michael R. Turner et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model
- (2018) Ninad Varkhede et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- The Increasingly Human and Profitable Monoclonal Antibody Market
- (2018) António L. Grilo et al. TRENDS IN BIOTECHNOLOGY
- Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
- (2018) Beate Bittner et al. BIODRUGS
- Subcutaneous delivery of monoclonal antibodies: How do we get there?
- (2018) Margarida Viola et al. JOURNAL OF CONTROLLED RELEASE
- Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers
- (2017) D. S. Collins et al. PHARMACEUTICAL RESEARCH
- Biophysical properties of the clinical-stage antibody landscape
- (2017) Tushar Jain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- THPdb: Database of FDA-approved peptide and protein therapeutics
- (2017) Salman Sadullah Usmani et al. PLoS One
- Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I–III Clinical Trials
- (2016) Lei Diao et al. CLINICAL PHARMACOKINETICS
- First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis
- (2016) Yanli Zhuang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A comparison of biophysical characterization techniques in predicting monoclonal antibody stability
- (2016) Geetha Thiagarajan et al. mAbs
- Evaluating and Reporting the Immunogenicity Impacts for Biological Products—a Clinical Pharmacology Perspective
- (2015) Yow-Ming C. Wang et al. AAPS Journal
- Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site
- (2014) Hanne M. Kinnunen et al. JOURNAL OF CONTROLLED RELEASE
- Survey of monoclonal antibody disposition in man utilizing a minimal physiologically-based pharmacokinetic model
- (2014) Yanguang Cao et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
- (2013) Miroslav Dostalek et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects
- (2013) Yanli Zhuang et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetics and pharmacodynamics of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, following single-dose administration by subcutaneous and intravenous routes to healthy subjects
- (2013) Xiaoping Zhang et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- The Antibody Drug Absorption Following Subcutaneous or Intramuscular Administration and Its Mathematical Description by Coupling Physiologically Based Absorption Process with the Conventional Compartment Pharmacokinetic Model
- (2013) Liang Zhao et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies
- (2013) Yanguang Cao et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- The Lymphatic System Plays a Major Role in the Intravenous and Subcutaneous Pharmacokinetics of Trastuzumab in Rats
- (2013) Annette M. Dahlberg et al. MOLECULAR PHARMACEUTICS
- Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
- (2012) Wolfgang F. Richter et al. AAPS Journal
- Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
- (2012) Abhijit Chakraborty et al. CLINICAL PHARMACOKINETICS
- Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration
- (2012) Yanan Zheng et al. mAbs
- Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
- (2011) Zhenhua Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies
- (2011) Jennifer Q. Dong et al. CLINICAL PHARMACOKINETICS
- Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
- (2011) Liviawati Sutjandra et al. CLINICAL PHARMACOKINETICS
- Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
- (2011) Dhaval K. Shah et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
- (2010) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males
- (2010) Chad K. Oh et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Microvascular fluid exchange and the revised Starling principle
- (2010) J. Rodney Levick et al. CARDIOVASCULAR RESEARCH
- Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Nathanael L. Dirks et al. CLINICAL PHARMACOKINETICS
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects
- (2009) Zhenhua Xu et al. JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started